School of Medicine
Showing 11-20 of 218 Results
Latha Palaniappan, MD, MS
Clinical Professor, Medicine - General Medical Disciplines
Current Research and Scholarly Interests Dr. Palaniappan has completed over 50 studies spanning 15 years in the areas of ethnicity, obesity, and diabetes risk.
Professor of Ophthalmology
Current Research and Scholarly Interests Interactions of electric field and light with biological cells and tissues and their applications to diagnostics, therapeutics and prosthetics, primarily in ophthalmology.
Specific fields of interest include:
Minimally-invasive optical therapeutics;
Electronic retinal prosthesis;
Microsurgical and cell-surgical technologies;
Optical imaging and spectroscopy;
Electronic control of cells and tissues;
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences) at the Stanford University Medical Center
Current Research and Scholarly Interests Research focused on developing interventions for management of side effects of cancer treatments (e.g., sleep disturbance, fatigue, depression, anxiety).
Jonathan P. Palma
Clinical Assistant Professor, Pediatrics - Neonatal and Developmental Medicine
Current Research and Scholarly Interests Analytics: Stanford Children's Health enterprise data warehouse; reporting business and clinical metrics; text and predictive analytics; mining clinical data to generate new knowledge.
Clinical informatics: optimization of commercial EMRs to support complex clinical workflows in newborn intensive care; clinical decision support; real-time clinical dashboards; electronic sign-out tools; IT-supported patient/family communication.
Associate Professor of Neurosurgery
Current Research and Scholarly Interests For most areas of the mammalian brain, the production of new nerve cells or neurons is restricted to fetal development. However, there are exceptions to the rule. Some areas of the brain continue to make new neurons throughout life. This neurogenesis is mediated by neural stem cells and our research goals are to understand how stem cell activity and fate are controlled. Ultimately, we hope to harness the nascent potential of stem cells to treat neurological injury and disease.